Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (Orbit-AF II)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Anticoagulants; Antithrombotics
- Indications Atrial fibrillation; Embolism and thrombosis
- Focus Therapeutic Use
- Acronyms Orbit-AF II
- 21 Jul 2020 Biomarkers information updated
- 10 Oct 2013 Planned End Date changed from 1 Feb 2017 to 1 Mar 2017 as reported by ClinicalTrials.gov.
- 05 Feb 2013 Planned End Date changed from 1 Jan 2017 to 1 Feb 2017 as reported by ClinicalTrials.gov.